(Q51826640)
Statements
Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration. (English)
1 reference
Petros P Sfikakis
1 reference
Panagiotis G Theodossiadis
1 reference
Vasilios S Liarakos
1 reference
Ioannis A Vergados
1 reference
George P Theodossiadis
1 reference
10 February 2009
1 reference
147
1 reference
5
1 reference
825-30, 830.e1
1 reference